HGHSX — The Hartford Healthcare Fund
Data updated: 2026-06-25
HGHSX — The Hartford Healthcare Fund data: holdings, portfolio allocation, expenses, performance, cashflows, risk and SEC filings. United States Health Care Equity · $729.19M AUM · 1.35% expense ratio · 11.8% 1-yr return. From SEC regulatory filings.
HGHSX Fund Overview
HGHSX — The Hartford Healthcare Fund is a US mutual fund managed by Hartford Mutual Funds, INC, categorised as United States Health Care Equity. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US mutual fund
- Manager: Hartford Mutual Funds, INC
- Category: United States Health Care Equity
- Assets under management: $729.19M
- 1-year return: 11.8%
- Ticker: HGHSX
- SEC CIK: 0001006415
- SEC series ID: S000003576
- Share class ID: C000040934
HGHSX Holdings
Top 10 holdings of The Hartford Healthcare Fund by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets |
|---|---|
| Eli Lilly & Co | 12.11% |
| Merck & Co Inc | 6.30% |
| Johnson & Johnson | 5.81% |
| UnitedHealth Group Inc | 5.54% |
| Intuitive Surgical Inc | 3.62% |
| AbbVie Inc | 3.09% |
| Abbott Laboratories | 2.80% |
| Danaher Corp | 2.68% |
| Edwards Lifesciences Corp | 2.54% |
| CVS Health Corp | 2.44% |
HGHSX Portfolio Allocation
Asset-class allocation of The Hartford Healthcare Fund by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 98.4% |
| Cash & Equivalents | 0.5% |
HGHSX Performance
Total returns for HGHSX (as of 2026-08-01), from SEC filings.
| Period | Total return |
|---|---|
| YTD | -4.4% |
| 1 year | 11.8% |
| 3 years (annualised) | 4.6% |
| 5 years (annualised) | 1.3% |
HGHSX Risk Information
Risk metrics for HGHSX, derived from monthly returns in SEC filings.
- 1-year volatility (annualised): 16.6%
HGHSX Costs and Fees
HGHSX costs about $135 per $10,000 invested per year in fund expenses.
- Net expense ratio: 1.35%
- Gross expense ratio: 1.35%
- Portfolio turnover: 49%
- Brokerage commissions: 4.11 bps of average net assets (SEC N-CEN)
HGHSX Cashflows
Over the 12 months to 2026-04, The Hartford Healthcare Fund had net outflows of $189.99M, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2026-04 | −$15.32M |
| 2026-03 | −$46.93M |
| 2026-02 | −$11.05M |
| 2026-01 | −$7.38M |
| 2025-12 | $16.11M |
| 2025-11 | −$10.29M |
HGHSX Debt Constituents
No individual debt constituents are reported in The Hartford Healthcare Fund's latest SEC N-PORT filing.
HGHSX Prospectus and SEC Filings
Official The Hartford Healthcare Fund filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
Related Funds
Other United States Health Care Equity funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.